Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children

Status Completed

Clinical Trial Summary

To determine the efficacy of tacrolimus in the management of NS(nephrotic syndrome) , the investigators designed this prospective study. The investigators will enroll 100 children with NS(frequent relapse steroid dependent NS, steroid resistance NS) who will be treated with tacrolimus (0.1-0.2 mg/kg/day in two divided doses over 12 h adjusted to a trough level between 5 and 10 ng/ml) for 12 months in combination with low-dose steroids. Other therapies will be included angiotensin-converting enzyme inhibitors, antihypertensive drugs, multivitamins and lipid-lowering agents.

Follow-up is every second week for the first 4 weeks, then monthly. After initiation of tacrolimus therapy, blood was drawn each visit to determine tacrolimus trough levels.

Clinical Trial Description

Subsequently , monthly measurements were made until stable levels of tacrolimus were achieved. Urine was analyzed for proteinuria at each visit. Serum creatinine, glucose, albumin and alanine aminotransferase were measured and complete blood counts were obtained at each visit during the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01162005
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	July 2010
Completion date	October 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02238418` - Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.	Phase 4
Completed	`NCT01895894` - Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome	Phase 4
Completed	`NCT01411982` - Role of PACAP in Nehprotic Syndrome	N/A
Recruiting	`NCT00308321` - Long Term Tapering or Standard Steroids for Nephrotic Syndrome	Phase 4
Active, not recruiting	`NCT03326037` - Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
Recruiting	`NCT01240564` - The Nephrotic Syndrome Study Network (NEPTUNE)	N/A
Completed	`NCT01252901` - Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases	N/A
Completed	`NCT01197040` - Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome	Phase 3
Terminated	`NCT00883636` - Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis	N/A
Completed	`NCT00035334` - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis	Phase 2/Phase 3
Terminated	`NCT00004466` - Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome	Phase 2
Terminated	`NCT04558892` - Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.	Phase 2/Phase 3
Completed	`NCT02257697` - A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome	Phase 3
Completed	`NCT00362531` - Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome	Phase 2/Phase 3
Completed	`NCT00289328` - Glucocorticoid-induced Osteopenia in Children	N/A
Recruiting	`NCT04759274` - Diuretic Tuner Clinical Decision Support	N/A
Completed	`NCT00001212` - Drug Therapy in Lupus Nephropathy	Phase 2
Recruiting	`NCT05623033` - The Predictive Value of Dynamic Changes of CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection
Completed	`NCT03332420` - The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
Not yet recruiting	`NCT05904197` - Effectiveness of Educational Gamified Cards About Nephrotic Syndrome	N/A